AMGEN INC

Biological Products, (No Diagnostic Substances) | SIC: 2836
Phone: (805)447-1000
CIK: 0000318154
EIN: 953540776
State Location: CA
State of Inc.: DE
Tickers:
  • Nasdaq:AMGN

Form: 25-NSE

Filing Date: 24 Feb 2026
Report Date:
Accepted: 24 Feb 2026 02:30 p.m.
Accession Number: 0001354457-26-000212
Act: 34
File Number: 000-12477
Film Number: 26672174

Documents

Primary Document
Accepted: 24 Feb 2026 02:30 p.m.